Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.61B |
| 2 |
Microsoft
MSFT
|
+$1.17B |
| 3 |
Broadcom
AVGO
|
+$366M |
| 4 |
Merck
MRK
|
+$343M |
| 5 |
Meta Platforms (Facebook)
META
|
+$260M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$609M |
| 2 |
CMA
Comerica
CMA
|
+$512M |
| 3 |
CADE
Cadence Bank
CADE
|
+$422M |
| 4 |
Johnson & Johnson
JNJ
|
+$331M |
| 5 |
Western Digital
WDC
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.81% |
| 2 | Financials | 17.07% |
| 3 | Industrials | 12.55% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Healthcare | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1751
TFI International
TFII
$9.91B
| $31.2M | 0.01% |
287,321
+129,242
| +82% | +$14.4M |
2020 Q4
21 quarters
|
|
1752
Village Super Market
VLGEA
$674M
| $31.2M | 0.01% |
737,682
+892
| +0.1% | +$34.2K |
2013 Q2
51 quarters
|
|
1753
AvePoint
AVPT
$2.98B
| $31M | 0.01% |
3,264,082
+666,422
| +26% | +$7.51M |
2023 Q1
12 quarters
|
|
1754
TriNet
TNET
$2.98B
| $31M | 0.01% |
851,372
-42,329
| -5% | -$2.02M |
2015 Q2
43 quarters
|
|
|
CRNX
1755
DELISTED
Crinetics Pharmaceuticals
CRNX
| $30.9M | 0.01% |
852,258
+303,281
| +55% | +$13.5M |
2025 Q1
4 quarters
|
|
1756
Boyd Gaming
BYD
$4.8B
| $30.9M | 0.01% |
375,858
+54
| +0% | +$4.53K |
2013 Q2
51 quarters
|
|
1757
Arcus Biosciences
RCUS
$3.21B
| $30.8M | 0.01% |
1,426,223
-97,934
| -6% | -$2.12M |
2021 Q2
19 quarters
|
|
1758
Robert Half
RHI
$3.87B
| $30.7M | 0.01% |
1,208,303
-236,683
| -16% | -$6.26M |
2013 Q2
51 quarters
|
|
1759
Astera Labs
ALAB
$61.8B
| $30.7M | 0.01% |
280,637
+43,967
| +19% | +$6.26M |
2024 Q3
6 quarters
|
|
|
AL
1760
DELISTED
Air Lease Corp
AL
| $30.7M | 0.01% |
472,457
-3,311,257
| -88% | -$214M |
2014 Q2
47 quarters
|
|
1761
Amerant Bancorp
AMTB
$1.15B
| $30.6M | 0.01% |
1,388,926
+133,050
| +11% | +$2.86M |
2021 Q1
20 quarters
|
|
1762
Financial Institutions
FISI
$778M
| $30.4M | 0.01% |
957,667
+1,761
| +0.2% | +$56.7K |
2013 Q2
51 quarters
|
|
1763
ASE Group
ASX
$116B
| $30.3M | 0.01% |
1,399,553
+125,324
| +10% | +$2.63M |
2013 Q2
51 quarters
|
|
1764
World Acceptance Corp
WRLD
$800M
| $30.3M | 0.01% |
224,602
-13,277
| -6% | -$1.78M |
2013 Q2
51 quarters
|
|
1765
HealthStream
HSTM
$929M
| $30.2M | 0.01% |
1,456,043
+87,177
| +6% | +$1.86M |
2013 Q2
51 quarters
|
|
1766
Madison Square Garden
MSGS
$9.61B
| $30.1M | 0.01% |
93,720
-31,081
| -25% | -$9.26M |
2013 Q2
51 quarters
|
|
1767
Oil-Dri
ODC
$1.32B
| $30M | 0.01% |
461,334
-56,769
| -11% | -$3.46M |
2013 Q2
51 quarters
|
|
1768
RXO
RXO
$3.52B
| $29.9M | 0.01% |
2,048,903
+504,955
| +33% | +$7.41M |
2023 Q1
12 quarters
|
|
1769
Ambev
ABEV
$44.7B
| $29.9M | 0.01% |
10,240,752
-77,573
| -0.8% | -$222K |
2013 Q4
49 quarters
|
|
1770
Park Hotels & Resorts
PK
$3.1B
| $29.8M | 0.01% |
2,834,320
+102,160
| +4% | +$1.13M |
2017 Q1
36 quarters
|
|
1771
Donegal Group Class A
DGICA
$674M
| $29.8M | 0.01% |
1,737,266
+7,345
| +0.4% | +$133K |
2013 Q2
51 quarters
|
|
1772
Driven Brands
DRVN
$1.92B
| $29.8M | 0.01% |
2,362,430
+200,788
| +9% | +$2.83M |
2022 Q1
16 quarters
|
|
1773
Intellia Therapeutics
NTLA
$1.7B
| $29.7M | 0.01% |
2,318,110
+386,261
| +20% | +$4.92M |
2018 Q3
30 quarters
|
|
1774
CG Oncology
CGON
$6.06B
| $29.7M | 0.01% |
438,673
-22,459
| -5% | -$1.27M |
2025 Q1
4 quarters
|
|
1775
Vishay Precision Group
VPG
$1B
| $29.6M | 0.01% |
682,726
-24,941
| -4% | -$1.13M |
2013 Q2
51 quarters
|
|
Similar funds
Dimensional Fund Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Dimensional Fund Advisors held 3,312 positions worth $481B, up 0.98% from $477B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q1 2026 filing shows 72 new, 1,935 increased, 1,135 reduced and 97 closed positions. Its largest new stake was Versant Media Group: 1,127,961 shares worth $41.7M. The largest sale was AstraZeneca, an estimated $609M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2026 buy was Versant Media Group: 1,127,961 shares worth $41.7M.
- Dimensional Fund Advisors added most to Amazon in Q1 2026, an estimated $1.61B increase.
- Dimensional Fund Advisors's biggest Q1 2026 reduction was Johnson & Johnson, cutting an estimated $331M.
- Dimensional Fund Advisors fully exited AstraZeneca in Q1 2026, selling an estimated $609M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $481B portfolio in Q1 2026.
- Dimensional Fund Advisors opened 72 new positions and closed 97 in Q1 2026.
- Dimensional Fund Advisors's portfolio value rose 0.98% quarter-over-quarter to $481B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.